What is PT Sejahteraraya Anugrahjaya Tbk's (SRAJ.JK) StockRank?

MoatMap's StockRank for PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) is 13/100, with a Strong Sell signal. This is a composite score combining Quality (30), Value (14), and Momentum (46) factor ranks across MoatMap's universe of 25,000+ stocks.

Does PT Sejahteraraya Anugrahjaya Tbk have an economic moat?

PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is PT Sejahteraraya Anugrahjaya Tbk a buy, hold, or sell?

MoatMap's current signal for PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is PT Sejahteraraya Anugrahjaya Tbk in?

PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) operates in the Healthcare sector, specifically the Medical Care Facilities industry (Indonesia).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

SRAJ.JK

Strong SellSinker

PT Sejahteraraya Anugrahjaya Tbk · Healthcare · Indonesia · $9.2B · Avg Vol: $4K/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-29.5%

D/E

5.4x

Dividend %

—

COMPANY DESCRIPTION

PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. The company manages and operates hospitals under the Mayapada Hospital name for neuroscience center, uro-nephrology center, cardiovascular center, gastro hepatology center, liver center, oncology center, orthopedic center,...

FINANCIAL SUMMARY (IDR)

Year	2021	2022	2023	2024	2025	CAGR	TTM
Revenue	—	1.9T	2.5T	2.3T	2.6T	10.2%	2.7T
EPS (IDR)	13.77	-3.69	-3.21	-1.96	-16.31	—	-30.30
Shares	—	12.0B	12.0B	12.0B	12.2B	+2.0%	12.2B
Debt	—	1.7T	1.7T	1.7T	4.7T	39.6%	5.9T
Equity	—	1.9T	1.9T	1.8T	1.3T	-11.1%	—
Op CF	—	210.5B	55.9B	273.2B	129.7B	-14.9%	293.6B
Inv CF	—	-678.2B	-585.4B	-532.3B	-612.1B	—	—
Fin CF	—	885.1B	-73.6B	9.7B	2.0T	—	—

Loading 1Y...

PRICE (1Y)+20.2%

SMA 50SMA 200

$0.7555

RSI (14)

36.5

52W High

$1.10

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

2.5%49.3

ROE

-29.5%25.7

GP/Assets

13.8%32.2

Op. Margin

-10.7%27.4

FCF/Assets

-10.8%28.7

Piotroski

431.0

Int. Cover

0.4x37.0

D/E Ratio

5.44x2.0

Current Ratio

1.40x23.3

Value

P/E (TTM)

—N/A

EV/EBITDA

523.0x0.9

P/FCF

—N/A

P/B

148.0x0.5

P/S

59.7x8.8

Div Yield

—N/A

Momentum

52W High %

69%46.9

RS 6M

2%67.0

SMA 50/200

0.87x26.0

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$9.2B

P/E (Forward)

—

Gross Margin

39.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SRAJ.JK are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
SRAJ.JK	PT Sejahteraraya Anugrahjaya Tbk(you)	$9.2B	13	Strong Sell
HEAL.JK	PT Medikaloka Hermina Tbk	$589M	35	Sell
LPKR.JK	PT Lippo Karawaci Tbk	$249M	40	Hold
SILO.JK	PT Siloam International Hospitals Tbk	$1.6B	78	Buy
SAME.JK	PT Sarana Meditama Metropolitan Tbk	$308M	46	Hold
MIKA.JK	PT Mitra Keluarga Karyasehat Tbk	$1.5B	84	Strong Buy
PYFA.JK	PT Pyridam Farma Tbk	$168M	9	Strong Sell
SOHO.JK	PT Soho Global Health Tbk	$1.2B	57	Hold
KAEF.JK	PT Kimia Farma Tbk	$150M	35	Hold
KLBF.JK	PT Kalbe Farma Tbk.	$2.0B	94	Strong Buy

Peer medians: ROE 9.2% · P/E 18.6x · Gross margin 35.8%

PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK): Stock Score Summary

PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) has a MoatMap StockRank of 13/100 based on Quality (30/100), Value (14/100), and Momentum (46/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price	$0.76
Market Cap	$9.2B
Price/Book	148.04
Return on Equity	-29.5%
Return on Invested Capital	2.5%
Debt/Equity	5.44x
Gross Margin	39.0%
Operating Margin	-10.7%
Revenue Growth	9.8%
Free Cash Flow	$-47M

PT Sejahteraraya Anugrahjaya Tbk operates in the Medical Care Facilities industry, part of the Healthcare sector (Indonesia).

Frequently Asked Questions

What is PT Sejahteraraya Anugrahjaya Tbk’s (SRAJ.JK) StockRank?: MoatMap’s StockRank for PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) is 13/100, with a Strong Sell signal. It is a composite of Quality (30), Value (14), and Momentum (46) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does PT Sejahteraraya Anugrahjaya Tbk have an economic moat?: PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is PT Sejahteraraya Anugrahjaya Tbk a buy, hold, or sell?: MoatMap’s current signal for PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is PT Sejahteraraya Anugrahjaya Tbk in?: PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK) operates in the Healthcare sector, specifically the Medical Care Facilities industry (Indonesia).